Dr. Suresh S. Ramalingam

• Healthcare
• Pharma & Biotech
• Spain
• United Kingdom

AstraZeneca Phase III FLAURA trial supports Tagrisso’s potential as a new standard of care in 1st-line EGFR-mutated lung cancer

Phase III FLAURA trial results show Tagrisso reduced the risk of progression or death by more than half, with consistent…